{
    "N/R/U": null,
    "Applicant": "Novo Nordisk Inc.",
    "BLA Number": "103665",
    "Proprietary Name": "Novoseven, Novoseven Rt",
    "Proper Name": "Coagulation Factor VIIa (Recombinant)",
    "BLA Type": "351(a)",
    "Strength": "8.0MG",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "August 06, 2010",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "5605",
    "Submission Type": "Supplement",
    "License Number": "1261",
    "Product Number": "007",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "July 02, 2021",
    "drug": [
        {
            "name": "Coagulation Factor VIIa (Recombinant)",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3777"
        }
    ]
}